These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22082137)

  • 21. Botulinum toxin type A for the treatment of head and neck chronic myofascial pain syndrome: A systematic review and meta-analysis.
    Khalifeh M; Mehta K; Varguise N; Suarez-Durall P; Enciso R
    J Am Dent Assoc; 2016 Dec; 147(12):959-973.e1. PubMed ID: 27737756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accuracy of botulinum toxin injections in myofascial pain. Response to Gobel et al. Pain 2006;125:82-8.
    Reilich P; Schoser BGH
    Pain; 2007 Aug; 130(3):299. PubMed ID: 17532140
    [No Abstract]   [Full Text] [Related]  

  • 23. Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre study.
    Göbel H; Heinze A; Reichel G; Hefter H; Benecke R;
    Pain; 2006 Nov; 125(1-2):82-8. PubMed ID: 16750294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does myofascial and trigger point treatment reduce pain and analgesic intake in patients undergoing onabotulinumtoxinA injection due to chronic intractable migraine?
    Gandolfi M; Geroin C; Valè N; Marchioretto F; Turrina A; Dimitrova E; Tamburin S; Serina A; Castellazzi P; Meschieri A; Ricard F; Saltuari L; Picelli A; Smania N
    Eur J Phys Rehabil Med; 2018 Feb; 54(1):1-12. PubMed ID: 28750504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of botulinum toxin in treating myofascial pain and occlusal force characteristics of masticatory muscles in bruxism.
    Jadhao VA; Lokhande N; Habbu SG; Sewane S; Dongare S; Goyal N
    Indian J Dent Res; 2017; 28(5):493-497. PubMed ID: 29072209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of Botulinum Toxin for Treatment of Symptomatic Pelvic Floor Myofascial Pain in Women: A Systematic Review and Meta-analysis.
    Meister MR; Brubaker A; Sutcliffe S; Lowder JL
    Female Pelvic Med Reconstr Surg; 2021 Jan; 27(1):e152-e160. PubMed ID: 32301801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Botulinum toxin assessment, intervention and aftercare for paediatric and adult niche indications including pain: international consensus statement.
    Rawicki B; Sheean G; Fung VS; Goldsmith S; Morgan C; Novak I;
    Eur J Neurol; 2010 Aug; 17 Suppl 2():122-34. PubMed ID: 20633183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic use of botulinum toxin type A in treating neck and upper-back pain of myofascial origin: a pilot study.
    Lew HL; Lee EH; Castaneda A; Klima R; Date E
    Arch Phys Med Rehabil; 2008 Jan; 89(1):75-80. PubMed ID: 18164334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of chronic migraine headache with onabotulinumtoxinA.
    Gerwin R
    Curr Pain Headache Rep; 2011 Oct; 15(5):336-8. PubMed ID: 21547527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Botulinum toxin, lidocaine, and dry-needling injections in patients with myofascial pain and headaches.
    Venancio Rde A; Alencar FG; Zamperini C
    Cranio; 2009 Jan; 27(1):46-53. PubMed ID: 19241799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are the effects of botulinum toxin injection on myofascial trigger points placebo effects or needling effects?
    Hsieh RL; Lee WC
    Arch Phys Med Rehabil; 2008 Apr; 89(4):792-3; author reply 793. PubMed ID: 18374016
    [No Abstract]   [Full Text] [Related]  

  • 32. Localized myofascial pain responds better than referring myofascial pain to botulinum toxin injections.
    Abboud WA; Hassin-Baer S; Joachim M; Givol N; Yahalom R
    Int J Oral Maxillofac Surg; 2017 Nov; 46(11):1417-1423. PubMed ID: 28521968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relief of periorbital pain after acute angle closure glaucoma attack by botulinum toxin type A.
    Chien KH; Lu DW; Chen YH; Cheng JH; Chen JT
    J Glaucoma; 2010; 19(8):546-50. PubMed ID: 20164800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum toxin A (Botox) for treatment of proximal myofascial pain in complex regional pain syndrome: two cases.
    Safarpour D; Jabbari B
    Pain Med; 2010 Sep; 11(9):1415-8. PubMed ID: 20735753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of Localized and Referred Masticatory Myofascial Pain with Botulinum Toxin Injection.
    Montes-Carmona JF; Gonzalez-Perez LM; Infante-Cossio P
    Toxins (Basel); 2020 Dec; 13(1):. PubMed ID: 33374687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac arrest after trigger point injection.
    Gökçek E; Akelma H; Kaydu A
    Agri; 2019 Nov; 31(4):216-217. PubMed ID: 31741342
    [No Abstract]   [Full Text] [Related]  

  • 37. Effectiveness of botulinum toxin type A for the treatment of chronic masticatory myofascial pain: A case series.
    Baker JS; Nolan PJ
    J Am Dent Assoc; 2017 Jan; 148(1):33-39. PubMed ID: 28314397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trigger point injections for axial back pain in adolescents.
    Peterson E; Finkel J
    BMJ Case Rep; 2021 Jun; 14(6):. PubMed ID: 34167984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Botulinum toxin A in the treatment of headache syndromes and pericranial pain syndromes.
    Göbel H; Heinze A; Heinze-Kuhn K; Austermann K
    Pain; 2001 Apr; 91(3):195-199. PubMed ID: 11275374
    [No Abstract]   [Full Text] [Related]  

  • 40. Botulinum injection for the management of myofascial pain in the masticatory muscles. A prospective outcome study.
    Sidebottom AJ; Patel AA; Amin J
    Br J Oral Maxillofac Surg; 2013 Apr; 51(3):199-205. PubMed ID: 22871559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.